🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

59,53 USD

Máx. histórico

2.925,00

12010 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,96%

Rango 52 semanas

37,06 – 95,49

Variación hoy

-0,07%

Cierre anterior

59,57

Rango de hoy

59,25 – 60,89

Volumen hoy

1.327.132

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,88%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 19 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/02/2023 33,07 33,86 32,50 33,75 +2,37% 4,11% 587.200
16/02/2023 33,36 33,80 32,94 32,97 -3,17% 2,58% 616.000
15/02/2023 33,23 34,08 32,76 34,05 +1,13% 3,96% 632.400
14/02/2023 34,48 35,15 33,46 33,67 -2,69% 4,92% 905.400
13/02/2023 33,24 34,75 32,78 34,60 +4,47% 5,91% 688.000
10/02/2023 32,99 33,42 32,48 33,12 -0,12% 2,86% 814.800
09/02/2023 32,98 34,08 32,50 33,16 +1,78% 4,79% 737.200
08/02/2023 33,32 33,92 32,37 32,58 -3,09% 4,65% 817.000
07/02/2023 33,54 34,24 32,06 33,62 +0,33% 6,50% 1.529.600
06/02/2023 35,37 35,99 32,23 33,51 -8,79% 10,63% 1.650.400
03/02/2023 36,36 37,71 36,23 36,74 -0,73% 4,07% 615.300
02/02/2023 35,75 37,01 35,47 37,01 +4,87% 4,31% 726.100
01/02/2023 34,85 35,88 34,27 35,29 +0,86% 4,61% 768.000
31/01/2023 33,51 35,03 33,51 34,99 +5,14% 4,54% 854.500
30/01/2023 33,20 33,80 32,89 33,28 -0,98% 2,76% 807.900
27/01/2023 33,29 34,08 33,21 33,61 +0,99% 2,61% 427.200
26/01/2023 33,24 33,76 32,60 33,28 +0,94% 3,49% 598.500
25/01/2023 33,44 33,82 32,22 32,97 -2,80% 4,78% 756.200
24/01/2023 32,53 34,15 32,23 33,92 +3,73% 5,90% 799.700
23/01/2023 33,66 33,69 32,28 32,70 -3,14% 4,19% 1.232.700
20/01/2023 34,48 34,50 33,14 33,76 -0,50% 3,94% 843.600
19/01/2023 35,84 36,13 33,90 33,93 -5,72% 6,22% 907.800
18/01/2023 37,11 37,66 35,64 35,99 -2,49% 5,44% 828.000
17/01/2023 36,81 37,67 36,17 36,91 +0,24% 4,07% 937.600
13/01/2023 35,99 37,95 35,62 36,82 +1,85% 6,47% 1.037.600
12/01/2023 34,36 36,17 33,75 36,15 +5,03% 7,04% 938.300
11/01/2023 33,07 35,42 32,47 34,42 +4,21% 8,92% 1.657.700
10/01/2023 30,27 33,05 29,84 33,03 +9,08% 10,60% 1.850.000
09/01/2023 30,05 31,00 28,52 30,28 -18,99% 8,25% 3.497.400
06/01/2023 37,47 38,32 35,58 37,38 +0,78% 7,31% 946.400